VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

695 hedge funds and large institutions have $46.6B invested in Vertex Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 253 increasing their positions, 247 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
695
Holders Change
+7
Holders Change %
+1.02%
% of All Funds
15.91%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.37%
New
72
Increased
253
Reduced
247
Closed
58
Calls
$403M
Puts
$352M
Net Calls
+$50.8M
Net Calls Change
+$62.6M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$554M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$512M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$330M
4
Jennison Associates
Jennison Associates
New York
+$220M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$135M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$635M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$207M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$155M
4
Goldman Sachs
Goldman Sachs
New York
-$144M
5
Citadel Advisors
Citadel Advisors
Florida
-$134M
Name Holding Trade Value Shares
Change 		Shares
Change %
Allianz Asset Management
26
Allianz Asset Management
Germany
$340M +$33.9M +175,700 +11%
PI
27
Putnam Investments
Massachusetts
$310M -$27.9M -144,700 -8%
O
28
OrbiMed
New York
$308M -$37M -192,100 -11%
PAM
29
Panagora Asset Management
Massachusetts
$280M +$96.2M +499,019 +52%
TCIM
30
TIAA CREF Investment Management
New York
$276M -$71.6M -371,272 -21%
JIM
31
Jupiter Investment Management
United Kingdom
$273M -$54.4M -282,358 -17%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$271M +$7.78M +40,376 +3%
BB
33
BB Biotech
Switzerland
$264M -$5.78M -30,000 -2%
UBS AM
34
UBS AM
Illinois
$255M -$7.12M -36,920 -3%
Deutsche Bank
35
Deutsche Bank
Germany
$250M -$16.3M -84,362 -6%
AQR Capital Management
36
AQR Capital Management
Connecticut
$247M +$86.6M +449,549 +54%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$244M +$31.6M +163,766 +15%
Franklin Resources
38
Franklin Resources
California
$238M -$10.6M -54,820 -4%
American Century Companies
39
American Century Companies
Missouri
$221M +$4.43M +22,997 +2%
PAMU
40
Pictet Asset Management (UK)
United Kingdom
$211M -$22.7M -117,986 -10%
Legal & General Group
41
Legal & General Group
United Kingdom
$207M +$3.98M +20,630 +2%
Millennium Management
42
Millennium Management
New York
$194M +$66.4M +344,730 +52%
Charles Schwab
43
Charles Schwab
California
$180M +$4.86M +25,205 +3%
Sumitomo Mitsui Trust Group
44
Sumitomo Mitsui Trust Group
Japan
$175M +$3.32M +17,232 +2%
Prudential Financial
45
Prudential Financial
New Jersey
$175M +$114M +593,667 +190%
EVM
46
Eaton Vance Management
Massachusetts
$174M +$12.2M +63,266 +8%
1832 Asset Management
47
1832 Asset Management
Ontario, Canada
$172M +$135M +708,025 +360%
Aberdeen Group
48
Aberdeen Group
United Kingdom
$171M -$49.8M -258,307 -23%
Citadel Advisors
49
Citadel Advisors
Florida
$160M -$134M -696,560 -46%
Swiss National Bank
50
Swiss National Bank
Switzerland
$157M -$4.88M -25,300 -3%
1
2
3 4 5